NCT05014893

Brief Summary

This study investigates the neural mechanisms of cognitive function decline, cognitive assessment methods for subjects with mild cognitive dysfunction (Mild cognitive impairment, MCI, or cognitive decline milder than MCI), and the approaches used to improve and restore cognitive function.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Aug 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Aug 2021Dec 2026

First Submitted

Initial submission to the registry

August 1, 2021

Completed
5 days until next milestone

Study Start

First participant enrolled

August 6, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 20, 2021

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 22, 2025

Status Verified

May 1, 2025

Enrollment Period

5.4 years

First QC Date

August 1, 2021

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Cognitive function (SCD-9)

    The SCD-9 questionnaire is used to assess cognitive function of participants.

    Change from Baseline Cognitive test results at 3 months.

  • Change in Cognitive function (MoCA)

    The Montreal Cognitive Assessment test is used to assess cognitive function of participants.

    Change from Baseline Cognitive test results at 3 months.

  • Change in Cognitive function (AD8)

    The AD8 test is used to assess cognitive function of participants.

    Change from Baseline Cognitive test results at 3 months.

  • Change in Cognitive function (CDR)

    The Clinical Dementia Rating (CDR) test is used to assess cognitive function of participants.

    Change from Baseline Cognitive test results at 3 months.

Secondary Outcomes (2)

  • Change in Physical capacity (TUG)

    Change from Baseline physical capacity test results at 3 months.

  • Change in Physical capacity (chair standing)

    Change from Baseline physical capacity test results at 3 months.

Other Outcomes (1)

  • Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]

    Up to 24 months.

Study Arms (2)

Control

NO INTERVENTION

Control group, without specific treatments

Cognitive training

EXPERIMENTAL

This group receives treatments to improve cognitive function.

Combination Product: multi-modal targeted intervention (e.g., cognitive training, exercise, games)

Interventions

The Intervention group will be given recommended interventions tailored to individuals based on their risks (e.g., physical exercise programs, cognitive training, dietary advice, control of blood pressure and cholesterol, healthy diet, control obesity, stop smoking,reduce alcohol excess)

Cognitive training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults being able to walk at least a block, and
  • Adults with subjective cognitive decline (SCD), or
  • Adults with mild cognitive impairment (MCI), or
  • Adults with normal cognitive function

You may not qualify if:

  • Clinical diagnosis of dementia
  • Adults who cannot follow the protocal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Research Center for Rehabilitation Technical Aids

Beijing, Beijing Municipality, 100176, China

RECRUITING

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

Cognitive TrainingExercise

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Pengxu Wei

    National Research Center for Rehabilitation Technical Aids

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

August 1, 2021

First Posted

August 20, 2021

Study Start

August 6, 2021

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 22, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations